论文部分内容阅读
目的探讨顽固性阵发性位置性眩晕患者治疗中高压氧与马来酸桂哌齐特的临床价值。方法选取2013-2014年我院收治的阵发性位置性眩晕患者60例,平均分为2组,对照组行常规治疗,观察组在常规治疗基础上联合马来酸桂哌齐特与高压氧治疗。结果治疗1疗程后观察组患者临床治疗痊愈率与有效率均明显高于对照组(P<0.05),各项临床症状改善时间均短于对照组(P<0.05)。结论高压氧与马来酸桂哌齐特联合常规疗法能够有效改善顽固性阵发性位置性眩晕患者的临床症状,缩短患者症状改善时间,具有较高的临床价值。
Objective To investigate the clinical value of hyperbaric oxygen and cinepazide maleate in patients with refractory paroxysmal positional vertigo. Methods Sixty patients with paroxysmal positional vertigo admitted to our hospital from 2013 to 2014 were divided into two groups randomly. The control group received routine treatment. The observation group was treated with cinepazide maleate combined with hyperbaric oxygen treatment. Results After 1 course of treatment, the cure rate and effective rate of clinical treatment in observation group were significantly higher than those in control group (P <0.05), and the improvement time of clinical symptoms were shorter than that in control group (P <0.05). Conclusion The combination of hyperbaric oxygen and cinepazide maleate conventional therapy can effectively improve the clinical symptoms of patients with refractory paroxysmal positional vertigo and shorten the time for improvement of symptoms in patients with high clinical value.